JPRN-UMIN000016188已完成未知
Effect of tolvaptan in decompensated liver cirrhosis patients - Effect of tolvaptan inliver cirrhosis patients
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 95years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)The anuric patients (2)Patients with urinary retention (3) hypernatremia (4)Patients with poorly controlled hepatocellular carcinoma and hepatic encephalopathy were exclude
研究者
相似试验
招募中
不适用
Safety and efficacy study of four weeks oral administration of tolvaptan in liver cirrhotic patients with hyponatremia and ascitesDiseases of the digestive systemKCT0000569Konkuk University Medical Center104
招募中
不适用
Effect of Tolvaptan on polycystic liver and kidney is autosomal dominant polycystic kidney diseaseADPKDJPRN-UMIN000016998Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine5
招募中
不适用
Tolvaptan as A treatment for Refractory Cirrhotic Ascites in Japanese population (TARCAJa study)Cirrhotic patients with ascites unresponsive to standard diuretic therapyJPRN-UMIN000020094Mitsui Memorail Hospital Department of Gastroenterology200
已完成
不适用
se experience of tolvaptan for end stage liver disease waiting for liver transplantation.end stage liver diseaseJPRN-UMIN000027096The University of Tokyo Hepato-biliary-pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine10
已完成
2 期
Dose Exploring and Setting Study for Tolvaptan to Treat Hepatic Cirrhosis With AscitesAscitesHepatic CirrhosisNCT01349335Otsuka Beijing Research Institute180